Multiple Sclerosis Patients Knowledge in Saudi Arabia

References

1. ↵
   1. Goldenberg MM

   (2012) Multiple Sclerosis Review. PT 37, 175–184.
2. 1. Ascherio A,
   2. Munger KL

   (2007) Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann Neurol 61, 288–299.
3. ↵
   1. Dyment DA,
   2. Ebers GC,
   3. Sadovnick AD

   (2004) Genetics of multiple sclerosis. Lancet Neurol 3, 104–110.
4. ↵
   1. Hudaif HSA,
   2. Bwardi NA,
   3. Kojan S

   (2014) Assessment of multiple sclerosis awareness and knowledge among the Saudi population in Riyadh City. Multiple Sclerosis and Related Disorders 3, 758.
5. ↵
   1. Berer K,
   2. Krishnamoorthy G

   (2014) Microbial view of central nervous system autoimmunity. FEBS Lett 588, 4207–4213.
6. ↵
   1. Al-Hashel J,
   2. Besterman AD,
   3. Wolfson C

   (2008) The Prevalence of Multiple Sclerosis in the Middle East. Neuroepidemiology 31, 129–1237.
7. ↵
   1. Bohlega S,
   2. Inshasi J,
   3. Al Tahan AR,
   4. Madani AB,
   5. Qahtani H,
   6. Rieckmann P

   (2013) Multiple sclerosis in the Arabian Gulf countries: a consensus statement. J Neurol 260, 2959–2963.
8. ↵
   1. Giordano A,
   2. Uccelli MM,
   3. Pucci E,
   4. Martinelli V,
   5. Borreani C,
   6. Lugaresi A,
   7. et al.

   (2010) The Multiple Sclerosis Knowledge Questionnaire: a self-administered instrument for recently diagnosed patients. Mult Scler 16, 100–111.
9. ↵
   1. Bourhis Y,
   2. Chrétin S,
   3. Nouet S,
   4. Debouverie M

   (2014) Psychometric properties of the French version of the multiple sclerosis knowledge questionnaire. in 2014 Joint ACTRIMS-ECTRIMS Meeting. Boston, MA USA. Multiple Sclerosis Journal 20, 412.
10. ↵
    1. Abolfazli R,
    2. Elyasi A,
    3. Javadi MR,
    4. Gholami K,
    5. Torkamandi H,
    6. Amir-Shahkarami M,
    7. et al.

    (2014) Knowledge and attitude assessment of Iranian multiple sclerosis patients receiving interferon beta. Iran J Neurol 13, 160–167.
11. ↵
    1. Heesen C,
    2. Kasper J,
    3. Segal J,
    4. Kopke S,
    5. Muhlhauser I

    (2004) Decisional role preferences, risk knowledge and information interests in patients with multiple sclerosis. Mult Scler 10, 643–650.
12. ↵
    1. Kopke S,
    2. Kasper J,
    3. Flachenecker P,
    4. Meissner H,
    5. Brandt A,
    6. Hauptmann B,
    7. et al.

    (2017) Patient education programme on immunotherapy in multiple sclerosis (PEPIMS): a controlled rater-blinded study. Clin Rehabil 31, 250–261.
13. ↵
    1. Maybury CP,
    2. Brewin CR

    (1984) Social relationships, knowledge and adjustment to multiple sclerosis. J Neurol Neurosurg Psychiatry 47, 372–376.
14. ↵
    1. Ghojazadeh M,
    2. Taghizadeh M,
    3. Abdi S,
    4. Azami-Aghdash S,
    5. Andalib S,
    6. Farhoudi M

    (2014) Fear of Disease Progression in Patients with Multiple Sclerosis: Associations of Anxiety, Depression, Quality of Life, Social Support, MS Knowledge. Journal of Clinical Research & Governance 3, 141–146.